embryonic/iPS

Reprogramming cellular identity for disease modeling

by Alexey Bersenev on March 18, 2012 · 1 comment

in direct reprogramming,embryonic/iPS

Lecture: Bruce Conklin – Stem Cells: Not what they used to be

by Alexey Bersenev on March 5, 2012 · 0 comments

in educational,embryonic/iPS,lectures

Genomic instability in human pluripotent stem cells derivatives

by Alexey Bersenev on January 25, 2012 · 0 comments

in embryonic/iPS

Moving forward to GMP-grade manufacturing of iPS cells

by Alexey Bersenev on December 16, 2011 · 0 comments

in cell product,embryonic/iPS

Derivation and banking of clinical-grade embryonic stem cell lines

by Alexey Bersenev on December 7, 2011 · 1 comment

in embryonic/iPS

Ian Wilmut on the future of iPS cells, reprogramming and direct transdifferentiation

by Alexey Bersenev on December 5, 2011 · 0 comments

in direct reprogramming,embryonic/iPS

The pattern of genetic alterations in cultured human pluripotent stem cells

by Alexey Bersenev on November 29, 2011 · 0 comments

in embryonic/iPS

Lecture: Chris Parker – Human iPS cells in drug discovery and development

by Alexey Bersenev on November 1, 2011 · 0 comments

in embryonic/iPS,lectures

EU court bans embryonic stem cell-based patents – An update

by Alexey Bersenev on October 25, 2011 · 0 comments

in embryonic/iPS

EU court bans embryonic stem cell-based patents

by Alexey Bersenev on October 18, 2011 · 0 comments

in embryonic/iPS,events,web tools

← Previous Entries